Cristóbal León

2.0k total citations
16 papers, 1.5k citations indexed

About

Cristóbal León is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Cristóbal León has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Cristóbal León's work include Antifungal resistance and susceptibility (11 papers), Antibiotic Use and Resistance (5 papers) and Fungal Infections and Studies (5 papers). Cristóbal León is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Antibiotic Use and Resistance (5 papers) and Fungal Infections and Studies (5 papers). Cristóbal León collaborates with scholars based in Spain, United States and France. Cristóbal León's co-authors include Pedro Saavedra, Sergio Ruiz‐Santana, Francisco Álvarez-Lerma, Juan Nolla‐Salas, M. A. Mendes de Leon, José Garnacho‐Montero, Benito Almirante, Luis Ostrosky‐Zeichner, Carmen Castro and Francisco Molina and has published in prestigious journals such as Critical Care Medicine, Intensive Care Medicine and Critical Care.

In The Last Decade

Cristóbal León

15 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristóbal León Spain 15 1.2k 852 342 236 171 16 1.5k
Juan Nolla‐Salas Spain 14 1.1k 0.9× 829 1.0× 252 0.7× 248 1.1× 137 0.8× 25 1.5k
Bernard Camins United States 20 628 0.5× 331 0.4× 268 0.8× 128 0.5× 278 1.6× 59 1.2k
Trevor Van Schooneveld United States 15 623 0.5× 552 0.6× 291 0.9× 144 0.6× 372 2.2× 89 1.3k
Rodney Croos‐Dabrera United States 12 1.2k 1.0× 749 0.9× 163 0.5× 355 1.5× 564 3.3× 16 1.6k
Mireia Puig‐Asensio Spain 20 777 0.6× 687 0.8× 125 0.4× 67 0.3× 150 0.9× 57 1.2k
Khetam Hussein Israel 20 636 0.5× 442 0.5× 336 1.0× 103 0.4× 150 0.9× 60 1.7k
Luis Felipe Reyes Colombia 26 831 0.7× 849 1.0× 114 0.3× 256 1.1× 429 2.5× 107 2.0k
Elizabeth Dodds Ashley United States 19 500 0.4× 525 0.6× 256 0.7× 81 0.3× 154 0.9× 66 1.0k
Almudena Burillo Spain 22 540 0.4× 624 0.7× 108 0.3× 165 0.7× 290 1.7× 64 1.6k
M. A. Mendes de Leon Spain 8 573 0.5× 374 0.4× 181 0.5× 136 0.6× 73 0.4× 10 730

Countries citing papers authored by Cristóbal León

Since Specialization
Citations

This map shows the geographic impact of Cristóbal León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristóbal León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristóbal León more than expected).

Fields of papers citing papers by Cristóbal León

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristóbal León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristóbal León. The network helps show where Cristóbal León may publish in the future.

Co-authorship network of co-authors of Cristóbal León

This figure shows the co-authorship network connecting the top 25 collaborators of Cristóbal León. A scholar is included among the top collaborators of Cristóbal León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristóbal León. Cristóbal León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
León, Cristóbal, Michelle L. Jones, S R Palmer, & Hakim Azfar Ali. (2025). Aggressive EBV-Associated Burkitt Lymphoma Following Lung Transplant: A Case of PTLD in a Patient with Cystic Fibrosis. The Journal of Heart and Lung Transplantation. 44(4). S747–S747.
2.
Saavedra, Pedro, et al.. (2020). Five-year outcome of peripherally inserted central catheters in adults: a separated infectious and thrombotic complications analysis. Infection Control and Hospital Epidemiology. 42(7). 833–841. 15 indexed citations
3.
Bassetti, Matteo, José Garnacho‐Montero, Thierry Calandra, et al.. (2017). Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Medicine. 43(9). 1225–1238. 126 indexed citations
4.
León, Cristóbal, Sergio Ruiz‐Santana, Pedro Saavedra, et al.. (2016). Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. Critical Care. 20(1). 107–107. 79 indexed citations
5.
Martín‐Mazuelos, Estrella, Ana Loza, Carmen Castro, et al.. (2015). β-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Medicine. 41(8). 1424–1432. 29 indexed citations
6.
Bruyère, Rémi, Jean‐Pierre Quenot, Sébastien Prin, et al.. (2014). Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU. BMC Infectious Diseases. 14(1). 385–385. 24 indexed citations
7.
León, Cristóbal, Luis Ostrosky‐Zeichner, & Mindy G. Schuster. (2014). What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Medicine. 40(6). 808–819. 82 indexed citations
8.
León, Cristóbal, Sergio Ruiz‐Santana, Pedro Saavedra, et al.. (2012). Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Medicine. 38(8). 1315–1325. 75 indexed citations
9.
Molina, Francisco, et al.. (2012). Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Critical Care. 16(3). R105–R105. 51 indexed citations
10.
Ostrosky‐Zeichner, Luis, Bart Jan Kullberg, Eric J. Bow, et al.. (2010). Early treatment of candidemia in adults: a review. Medical Mycology. 49(2). 113–120. 79 indexed citations
11.
León, Cristóbal, Sergio Ruiz‐Santana, Pedro Saavedra, et al.. (2009). Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study. Critical Care Medicine. 37(5). 1624–1633. 273 indexed citations
12.
Charles, Pierre‐Emmanuel, Carmen Castro, Sergio Ruiz‐Santana, et al.. (2009). Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis?. Intensive Care Medicine. 35(12). 2146–2150. 25 indexed citations
13.
Álvarez-Lerma, Francisco, et al.. (2007). Risk factors for candidaemia in critically ill patients: a prospective surveillance study*. Mycoses. 50(4). 302–310. 80 indexed citations
14.
León, Cristóbal, Sergio Ruiz‐Santana, Pedro Saavedra, et al.. (2006). A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*. Critical Care Medicine. 34(3). 730–737. 475 indexed citations
15.
León, Cristóbal, Sergio Ruiz‐Santana, Jordi Rello, et al.. (2004). Benefits of minocycline and rifampin-impregnated central venous catheters. Intensive Care Medicine. 30(10). 1891–1899. 77 indexed citations
16.
Fernández, José Gutiérrez, et al.. (1992). Catheter-related bacteremia and fungemia. Diagnostic Microbiology and Infectious Disease. 15(7). 575–578. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026